Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Krauss · SciRah

Researcher profile · Semantic Scholar

J. Krauss

Share profile

J. Krauss — researcher profile on SciRah

h-index: 29
Works: 108
Citations: 5,760

Most-cited papers

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
R. Doebele, A. Drilon, L. Paz-Ares, S. Siena +34 more
2019The Lancet Oncology1,438 citations Open access
Semantic Scholar
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
D. Hong, M. Fakih, J. Strickler, J. Desai +30 more
2020New England Journal of Medicine867 citations Open access
Semantic Scholar
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
J. García-Aguilar, S. Patil, M. Gollub, Jin K. Kim +38 more
2022Journal of Clinical Oncology792 citations Open access
Semantic Scholar
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
A. Dasari, S. Lonardi, R. García-Carbonero, E. Élez +33 more
2023The Lancet271 citations Open access
Semantic Scholar
Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Jian-Li Wang, Scott Saffold, Xue-Tao Cao, J. Krauss +1 more
1998Journal of Immunology252 citations Open access
Semantic Scholar
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.
M. Fakih, S. Kopetz, Y. Kuboki, T. W. Kim +17 more
2021The Lancet Oncology245 citations
Semantic Scholar
Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402.
B. Kahl, F. Hong, Michael E. Williams, R. Gascoyne +11 more
2014Journal of Clinical Oncology181 citations Open access
Semantic Scholar
Systemic T cell adoptive immunotherapy of malignant gliomas.
G. Plautz, G. Barnett, David W. Miller, Bruce H. Cohen +5 more
1998Journal of Neurosurgery159 citations
Semantic Scholar
Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes.
H. Kagamu, Joseph E. Touhalisky, G. Plautz, J. Krauss +1 more
1996Cancer Research97 citations
Semantic Scholar
Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor.
M. J. Arca, J. Krauss, A. Aruga, M. Cameron +2 more
1996Cancer Gene Therapy91 citations
Semantic Scholar
Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study.
Wyatt C. To, B. Wood, J. Krauss, M. Strome +9 more
2000Archives of Otolaryngology - Head and Neck Surgery71 citations Open access
Semantic Scholar
Treatment of subcutaneous tumor with adoptively transferred T cells.
Liao-Min Peng, S. Shu, J. Krauss
1997Cellular Immunology66 citations
Semantic Scholar
Results of Eastern Cooperative Oncology Group Protocol E4402 (RESORT): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Low Tumor Burden Follicular Lymphoma
B. Kahl, F. Hong, Michael E. Williams, R. Gascoyne +3 more
201160 citations
Semantic Scholar
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy
D. Hovelson, C. Liu, Yugang Wang, Q. Kang +28 more
2017OncoTarget50 citations Open access
Semantic Scholar
T Cell-Mediated Tumor Rejection Displays Diverse Dependence Upon Perforin and IFN-γ Mechanisms That Cannot Be Predicted From In Vitro T Cell Characteristics1
Liao-Min Peng, J. Krauss, G. Plautz, S. Mukai +2 more
2000Journal of Immunology50 citations
Semantic Scholar
Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes
M. J. Arca, J. Krauss, S. Strome, M. Cameron +1 more
1996Cancer Immunology and Immunotherapy49 citations Open access
Semantic Scholar
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy: A Multicenter, Pilot, Randomized, Wait-List Controlled Trial.
R. Knoerl, Ellen M. Lavoie Smith, D. Barton, David A. Williams +3 more
2017Journal of Pain47 citations Open access
Semantic Scholar
Rituximab Extended Schedule or Retreatment Trial (RESORT) for Low Tumor Burden non-Follicular Indolent B-cell Non-Hodgkin Lymphomas: Eastern Cooperative Oncology Group Protocol E4402
Michael E. Williams, F. Hong, R. Gascoyne, Lynne I. Wagner +11 more
2016British Journal of Haematology47 citations Open access
Semantic Scholar
OA03.03 Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors
G. Falchook, B.-T. Li, K. A. Marrone, C. Bestvina +7 more
2022Journal of Thoracic Oncology45 citations Open access
Semantic Scholar
315O Sotorasib in combination with panitumumab in refractory KRAS G12C-mutated colorectal cancer: Safety and efficacy for phase Ib full expansion cohort
Y. Kuboki, R. Yaeger, M. Fakih, J. Strickler +10 more
2022Annals of Oncology43 citations Open access
Semantic Scholar
Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature
J. Grewal, Lauren B. Smith, Jerome D. Iii Winegarden, J. Krauss +2 more
2007Annals of Hematology41 citations
Semantic Scholar
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
K. Klute, M. Rothe, E. Garrett-Mayer, P. Mangat +14 more
2022JCO Precision Oncology38 citations
Semantic Scholar
Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours
R. Govindan, M. Fakih, T. Price, G. Falchook +13 more
2019Annals of Oncology37 citations Open access
Semantic Scholar
An Automated Intervention Did Not Improve Adherence to Oral Oncolytic Agents While Managing Symptoms: Results from a Two-arm Randomized Controlled Trial
A. Sikorskii, C. Given, B. Given, Eric Vachon +6 more
2018Journal of Pain and Symptom Management37 citations Open access
Semantic Scholar
Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT).
L. Wagner, Feng-Min Zhao, F. Hong, Michael E. Williams +11 more
2015Journal of Clinical Oncology35 citations Open access
Semantic Scholar
Emerging Systemic Therapies for Colorectal Cancer
Christine M. Veenstra, J. Krauss
2018Clinics in Colon and Rectal Surgery33 citations Open access
Semantic Scholar
OA02.02 Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRASG12C Inhibitor, Evaluated in NSCLC
R. Govindan, M. Fakih, T. Price, G. Falchook +13 more
2019Journal of Thoracic Oncology32 citations Open access
Semantic Scholar
T Cell-Mediated Tumor Rejection Displays Diverse Dependence Upon Perforin and IFN- g Mechanisms That Cannot Be Predicted From In Vitro T Cell Characteristics
S. Shu, P. Cohen, Liao-Min Peng, J. Krauss +1 more
200032 citations
Semantic Scholar
CodeBreak 100: Phase I study of AMG 510, a novel KRASG12C inhibitor, in patients (pts) with advanced solid tumors other than non-small cell lung cancer (NSCLC) and colorectal cancer (CRC).
D. Hong, J. Kuo, A. Sacher, F. Barlesi +10 more
2020Journal of Clinical Oncology27 citations
Semantic Scholar
Phase II study of durvalumab following neoadjuvant chemoRT in operable rectal cancer: NSABP FR-2.
T. George, G. Yothers, S. Jacobs, G. Finley +11 more
2022Journal of Clinical Oncology25 citations
Semantic Scholar
Is the problem list in the eye of the beholder? An exploration of consistency across physicians
J. Krauss, P. Boonstra, Anna V. Vantsevich, C. Friedman
2016J. Am. Medical Informatics Assoc.24 citations Open access
Semantic Scholar
Development, implementation, and initial evaluation of a foundational open interoperability standard for oncology treatment planning and summarization
J. Warner, Suzanne E. Maddux, K. Hughes, J. Krauss +11 more
2015J. Am. Medical Informatics Assoc.24 citations Open access
Semantic Scholar
Side Effects, Self-Management Activities, and Adherence to Oral Anticancer Agents
Yun Jiang, K. Wickersham, Xing-Yu Zhang, D. Barton +3 more
2019Patient Preference and Adherence23 citations Open access
Semantic Scholar
Retroviral-mediated gene transfer in human bone marrow cells growth in continuous perfusion culture vessels.
Peter G. Eipers, J. Krauss, B. Palsson, S. Emerson +2 more
1995Blood23 citations
Semantic Scholar
CodeBreak 100: Activity of AMG 510, a novel small molecule inhibitor of KRASG12C, in patients with advanced colorectal cancer.
M. Fakih, J. Desai, Y. Kuboki, J. Strickler +15 more
202022 citations
Semantic Scholar
Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction molecules
James K. C. Liu, J. Finke, J. Krauss, S. Shu +1 more
1998Cancer Immunology and Immunotherapy22 citations Open access
Semantic Scholar
MR of myelomatous meningitis.
D. Quint, R. A. Levy, J. Krauss
1995AJNR. American journal of neuroradiology16 citations
Semantic Scholar
A Randomized, Controlled Trial of Panax quinquefolius extract (CVT-E002) to Reduce Respiratory Infection in Patients with Chronic Lymphocytic Leukemia
K. High, D. Case, D. Hurd, B. Powell +9 more
2012The Journal of Supportive Oncology15 citations Open access
Semantic Scholar
Cytokines as an adjuvant to tumor vaccines: Efficacy of local methods of delivery
S. Kurane, M. Arca, A. Aruga, R. Krinock +2 more
1997Annals of Surgical Oncology13 citations Open access
Semantic Scholar
543P Entrectinib in NTRK fusion-positive NSCLC: Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
A. Drilon, L. Paz-Ares, R. Doebele, A. Farago +15 more
202012 citations Open access
Semantic Scholar
Successful Treatment of Refractory Low Grade Duodenal Lymphoma With Rituximab, an Anti-cd20 Monoclonal Antibody
Shazia S. Ahmed, A. Singh, J. Krauss, Tracey Wentz +1 more
2003American Journal of Clinical Oncology12 citations
Semantic Scholar
Efficacy of the Motivational Interviewing–Walk Intervention for Chemotherapy-Induced Peripheral Neuropathy and Quality of Life During Oxaliplatin Treatment
Grace A. Kanzawa-Lee, R. Ploutz-Snyder, J. Larson, J. Krauss +2 more
2021Cancer Nursing11 citations
Semantic Scholar
Development and Characteristics of a Multidisciplinary Colorectal Cancer Clinic
Joceline V. Vu, Arden M. Morris, Lillias H. Maguire, A. D. De Roo +5 more
2020American Journal of Surgery11 citations Open access
Semantic Scholar
Abstract CT131: Entrectinib inNTRK-fusion positive (NTRK-FP) non-small cell lung cancer (NSCLC): Integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1 and ALKA-372-001)
R. Doebele, L. Paz-Ares, A. Farago, Stephen V. Liu +14 more
2019Clinical Trials11 citations
Semantic Scholar
Targeted Gene Transfer for Adenocarcinoma Using a Combination of Tumor‐specific Antibody and Tissue‐specific Promoter
S. Kurane, J. Krauss, E. Watari, R. Kannagi +2 more
1998Japanese journal of cancer research : Gann11 citations Open access
Semantic Scholar
Expression of Major Histocompatibility Complex Antigens in Squamous Cell Carcinomas of the Head and Neck: Effects of Interferon Gene Transfer
O. Arosarena, Seema Baranwal, S. Strome, G. Wolf +3 more
1996Otolaryngology Head & Neck Surgery10 citations
Semantic Scholar
NSABP FR-2: Phase II study of durvalumab following neoadjuvant chemoRT in stage II-IV rectal cancer.
T. George, G. Yothers, S. Jacobs, G. Finley +8 more
2018Journal of Clinical Oncology9 citations
Semantic Scholar
Tumor immunology.
S. Shu, G. Plautz, J. Krauss, A. Chang
1997Journal of the American Medical Association (JAMA)9 citations
Semantic Scholar
Quantitating and assessing interoperability between electronic health records
E. Bernstam, J. Warner, J. Krauss, E. Ambinder +4 more
2022J. Am. Medical Informatics Assoc.8 citations Open access
Semantic Scholar
A phase 1 study of TPST-1495 as a single agent and in combination with pembrolizumab in patients with advanced solid tumors.
S. Ulahannan, J. Powderly, M. Johnson, J. Krauss +13 more
2023Journal of Clinical Oncology7 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Shu×9
Invite
S. Shu — researcher profile on SciRah
M. Fakih×7
Invite
M. Fakih — researcher profile on SciRah
J. Strickler×7
Invite
J. Strickler — researcher profile on SciRah
G. Plautz×7
Invite
G. Plautz — researcher profile on SciRah

×6

Invite

D. Hong — researcher profile on SciRah

C. Denlinger×6

Invite

C. Denlinger — researcher profile on SciRah

Invite

H. Henary — researcher profile on SciRah

G. Ngarmchamnanrith×6

Invite

G. Ngarmchamnanrith — researcher profile on SciRah

Invite

G. Falchook — researcher profile on SciRah

Invite

T. Price — researcher profile on SciRah

Invite

Y. Kuboki — researcher profile on SciRah

Invite

B. Besse — researcher profile on SciRah